Steven Cohen's BNTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 327,184 shares of BioNTech SE (BNTX) worth $30.44 M, representing 0.03% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in BNTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 341,311 shares. Largest reduction occurred in Q4 2024, reducing 361,993 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's BioNTech SE (BNTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioNTech SE (BNTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +327,184 | New Buy | 327,184 | $93.05 |
| Q4 2024 | -361,993 | Sold Out | 0 | $0.00 |
| Q3 2024 | -99,718 | Reduce 21.60% | 361,993 | $118.77 |
| Q2 2024 | +341,311 | Add 283.48% | 461,711 | $80.36 |
| Q1 2024 | +120,400 | New Buy | 120,400 | $92.25 |
| Q1 2023 | -302,600 | Sold Out | 0 | $0.00 |
| Q4 2022 | +192,600 | Add 175.09% | 302,600 | $150.22 |
| Q3 2022 | +110,000 | New Buy | 110,000 | $134.88 |
| Q1 2022 | -88,700 | Sold Out | 0 | $0.00 |
| Q4 2021 | +88,700 | New Buy | 88,700 | $257.80 |
Steven Cohen's BioNTech SE Investment FAQs
Steven Cohen first purchased BioNTech SE (BNTX) in Q4 2021, acquiring 88,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held BioNTech SE (BNTX) for 10 quarters since Q4 2021.
Steven Cohen's largest addition to BioNTech SE (BNTX) was in Q2 2024, adding 461,711 shares worth $37.1 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 327,184 shares of BioNTech SE (BNTX), valued at approximately $30.44 M.
As of the Q2 2026 filing, BioNTech SE (BNTX) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in BioNTech SE (BNTX) was 461,711 shares, as reported at the end of Q2 2024.